Live Feeds

Source map — Merck sees pivotal victory for $3B eye disease prospect

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
Fierce Biotech news 60%
Reuters news 60%
Endpoints News news 60%
Business Wire news 60%
Ophthalmology Times news 60%
FirstWord news 60%
www.philanthropy.com news 50%
explainx.ai news 50%
www.biopharmadive.com news 50%
www.aol.com news 50%
www.oann.com news 50%
www.forbes.com news 50%
www.youtube.com news 50%
www.azlyrics.com news 50%
whatdoesthatsongmean.com news 50%
sublimewiki.com news 50%
americanbazaaronline.com news 50%
thelogic.co news 50%
stockanalysis.com news 50%
simplywall.st news 50%
www.analyticsinsight.net news 50%
hoodline.com news 50%
www.biospace.com news 50%
www.insidehighered.com news 50%
www.investmentnews.com news 50%
richmond.com news 50%
finance.yahoo.com news 50%
www.cafepharma.com news 50%
lifescivoice.com news 50%
www.merckconnect.com news 50%
en.wikipedia.org news 50%
jobs.merck.com news 50%
www.merck.com news 50%
www.biobucks.co news 50%
trial.medpath.com news 50%
newzino.com news 50%
catalystalert.io news 50%
www.talk.bio news 50%
www.fiercebiotech.com news 50%